n-3 PUFAs reduce tumor load and improve survival in a NASH-tumor mouse model

BACKGROUND: With 9.1% of all cancer deaths, hepatocellular carcinoma is the second leading cause of cancer deaths worldwide. Due to the increasing prevalence of metabolic syndrome, nonalcoholic fatty liver disease (NAFLD) has evolved into a major risk factor for hepatocellular carcinoma development....

Descripción completa

Detalles Bibliográficos
Autores principales: Liebig, Marie, Dannenberger, Dirk, Vollmar, Brigitte, Abshagen, Kerstin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728677/
https://www.ncbi.nlm.nih.gov/pubmed/31523414
http://dx.doi.org/10.1177/2040622319872118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6728677/
https://www.ncbi.nlm.nih.gov/pubmed/31523414
http://dx.doi.org/10.1177/2040622319872118

Ejemplares similares